Nonadherence to depression treatment guidelines among veterans with diabetes mellitus

American Journal of Managed Care

Volumn 12, Issue 12, 2006, Pages 701-710

  Jones, Laura E ^a,d   Turvey, Carolyn ^e,f   Torner, James C ^d   Doebbeling, Caroline Carney ^b,c,d  

^a RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c REGENSTRIEF INSTITUTE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; EVALUATION; FEMALE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPTIMAL DRUG DOSE; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES; VETERAN;

ADULT; AGED; COHORT STUDIES; DEPRESSION; DIABETES MELLITUS; FEMALE; GUIDELINES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; UNITED STATES; VETERANS;

EID: 33845672614     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
2. Selim AJ, Fincke G, Ren XS, et al. Comorbidity assessments based on patient report: results from the Veterans Health Study. J Ambul Care Manage. 2004;27: 281-295.
3. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24: 1069-1078,
4. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569-580.
5. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157(suppl):1-45.
6. Management of Major Depressive Disorder Working Group. VHA/DoD Clinical Practice Guideline for Management of Major Depressive Disorder in Adults. Washington, DC: Dept of Veterans Affairs; 2000.
7. Kramer TL, Owen RR, Cannon D, et al. How well do automated performance measures assess guideline implementation for new-onset depression in the Veterans Health Administration? Jt Comm J Qual Saf. 2003;29:479-489.
8. Weilburg JB, O'Leary KM, Meigs JB, Hennen J, Stafford RS. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv. 2003;54:1233-1239.
9. Charbonneau A, Rosen AK, Ash AS, et al. Measuring the quality of depression care in a large integrated health system. Med Care. 2003;41:669-680.
10. Dobscha SK, Gerrity MS, Corson K, Bahr A, Cuilwik NM. Measuring adherence to depression treatment guidelines in a VA primary care clinic. Gen Hosp Psychiatry. 2003;25:230-237.
11. Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30:67-76.
12. Chen RS, Rosenheck R. Using a computerized patient database to evaluate guideline adherence and measure patterns of care for major depression. J Behav Health Serv Res. 2001;28:466-474.
13. McCombs JS, Shi L, Stimmel GL, Croghan TW. A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder. Clin Ther. 2002;24:1938-1959.
14. Katon WJ, Simon G, Russo J, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care. 2004;42: 1222-1229.
15. Harman JS, Edlund MJ, Fortney JC, Kallas H. The influence of comorbid chronic medical conditions on the adequacy of depression care for older Americans. J Am Geriatr Soc. 2005;53:2178-2183.
16. Busch SH, Leslie D, Rosenheck R. Measuring quality of pharmacotherapy for depression in a national health care system. Med Care. 2004;42:532-542.
17. Kerr EA, McGlynn EA, Van Vorst KA, Wickstrom SL. Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement. Jt Comm J Qual Improv. 2000;26: 203-216.
18. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58:55-61.
19. White T, Vanderplas A, Ory C, Dezii C, Chang E. Economic impact of patient adherence with antidepressant therapy within a managed care organization. Dis Manag Health Outcomes. 2003;11:817-822.
20. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-457.
21. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care. 2006;44:300-303.
22. Sood N, Treglia M, Obenchain RL, Dulisse B, Melfi CA, Croghan TW. Determinants of antidepressant treatment outcome. Am J Manag Care. 2000;6: 1327-1336.
23. Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM. Impact of antidepressant drug adherence on comorbid medication use and resource utilization. Arch Intern Mod. 2005;165:2497-2503.
24. Weilburg JB, Stafford RS, O'Leary KM, Meigs JB, Finkelstein SN. Costs of antidepressant medications associated with inadequate treatment. Am J Manag Care. 2004;10:357-365.
25. Charbonneau A, Rosen AK, Owen RR, et al. Monitoring depression care: in search of an accurate quality indicator. Med Care. 2004;42:522-531.
26. Klinkman MS. Competing demands in psychosocial care: a model for the identification and treatment of depressive disorders in primary care. Gen Hosp Psychiatry. 1997;19:98-111.
27. Kalsekar ID, Madhavan SM, Amonkar MM, Scott V, Douglas SM, Makela E. The effect of depression on health care utilization and costs in patients with type 2 diabetes. Manag Care Interface. 2006;19:39-46.
28. Miller DR, Safford MM, Pogach LM. Who has diabetes? best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(suppl 2):B10-B21.
29. Croghan TW, Melfi CA, Dobrez DG, Kniesner TJ. Effect of mental health specialty care on antidepressant length of therapy. Med Care. 1999;37(suppl Lilly):AS20-AS23.
30. Melfi CA, Croghan TW. Use of claims data for research on treatment and outcomes of depression care. Med Care. 1999;37(suppl Lilly):AS77-AS80.
31. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
32. Klabunde CN, Potosky AL, Legier JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53: 1258-1267.
33. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons Inc; 2000.
34. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25:464-470.
35. Jones LE, Turvey C, Carney Doebbeling C. Inadequate follow-up care for depression and its impact on antidepressant treatment duration among veterans with and without diabetes mellitus in the Veterans Health Administration. Gen Hosp Psychiatry. In Press.
36. McCombs JS, Nichol MB, Stimmel GL, Sclar DA, Beasley CM Jr, Gross LS. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry. 1990;51(suppl):60-71.